Review: Cardioselective Î²-blockers do not produce adverse respiratory effects in COPD
- COPD in the News. // AARC Times;Sep2010, Vol. 34 Issue 9, p89
The article offers information related to medicine. It discusses the studies related to treatments of patients with exacerbation of chronic obstructive pulmonary disease (COPD) using beta-blocker and antibiotics. It says that plastic surgeons in New Jersey performed a phrenic nerve decompression...
- Î²-blockers associated with reduced all-cause mortality in COPD. Tashkin, Donald P. // Evidence Based Medicine;Feb2012, Vol. 17 Issue 1, p31
The author comments on the article "Effect of Beta Blockers in Treatment of Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study," by PM Short and colleagues published in the "British Medical Journal." He argues that the limitations of the study include those that are common in...
- Î² blockers in COPD. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;6/5/2010, Vol. 340 Issue 7758, p1227
An online discussion concerning a study on the use of Î’ blockers to reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary diseases (COPD) is presented.
- Should Patients with COPD Exacerbations Receive Beta Blockers? Pierson, David J. // Critical Care Alert;Aug2008, Vol. 16 Issue 5, p37
The article presents the findings of a study that utilizes beta blockers on patients with chronic obstructive pulmonary disease (COPD) exacerbations.
- Use of Î² blockers in patients with COPD. Au, David H. // Thorax;Apr2008, Vol. 63 Issue 4, p296
The article discusses a paper published within this issue about the use of Î² blockers in patients with chronic obstructive pulmonary disease (COPD).
- Review: Cardioselective Î²-blockers do not produce adverse respiratory effects in COPD: COMMENTARY. Lacasse, Yves // ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p66
The article presents comments of the author on a study which found that cardioselective Î²-blockers do not produce adverse respiratory effects in COPD. The well-conducted meta-analysis by researchers of the study vividly illustrates one of the assumptions of the new paradigm of evidence-based...
- Should Patients with COPD Exacerbations Receive Beta Blockers? Pierson, David J. // Internal Medicine Alert;8/15/2008, Vol. 30 Issue 15, p113
The findings of this retrospective study of 825 patients hospitalized with COPD exacerbations indicate that the use of beta blockers in such patients is not harmful and may actually be associated with reduced mortality.
- 526 Use of beta blockers in HF patients with chronic obstructive pulmonary disease. Lourenco, P.; Mascarenhas, J.; Lopes, R.; Azevedo, A.; Bettencourt, P. // European Journal of Heart Failure. Supplements;
The article presents an abstract of the study "Use of Beta Blockers in HF Patients with Chronic Obstructive Pulmonary Disease," by P. Lourenco and colleagues.
- Impact of coronary angioplasty. Sanfilippo, Filippo; Santonocito, Cristina; Foex, Pierre; Quint, Jennifer K. // BMJ: British Medical Journal;2/1/2014, Vol. 348 Issue 7943, p23
A response from the author of the article "Effect of ÃŸ Blockers on Mortality After Myocardial Infarction in Adults With COPD: Population Based Cohort Study of UK Electronic Health care Records" in the November 22, 2013 issue, is presented.